Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
3 minute read

Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin
Today, 3:52 PM
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."

AMAM

Read More
1 minute read

Earnings Outlook For Heron Therapeutics

By Benzinga Insights
Today, 3:52 PM
Heron Therapeutics (NASDAQ:HRTX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Heron Therapeutics will report an earnings per share (EPS) of $-0.38.

HRTX

Read More
3 minute read

Heron Therapeutics Announces U.S. FDA Approval Of APONVIE For The Prevention Of Postoperative Nausea And Vomiting

By Benzinga Newsdesk
Today, 3:52 PM
  - APONVIE is the first and only intravenous (IV) formulation of a substance P/neurokinin-1 (NK1) receptor antagonist indicated for PONV - - Delivered via a single 30-second IV injection, APONVIE has demonstrated rapid achievement of therapeutic drug levels ideally suited for the surgical setting -

HRTX